FDA's AI Elsa, LawZero for AI Safety, and Meta's Ad Automation

episode

The AI News Daily Brief not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

U.S. troops are leaving Iraq. What does that mean for U.S. influence in the region? 12 min · 27 Sep 2026 · Consider This from NPR

NPR News: 09-27-2026 6PM EDT 5 min · 27 Sep 2026 · NPR News Now

First Thoughts - Grand Final (28.09.26) 29 min · 27 Sep 2026 · SEN Breakfast

SEN WA's Tim Gossage (28.09.26) 5 min · 27 Sep 2026 · SEN Breakfast

Decentering Men: Geht’s uns ohne Männer besser? 24 min · 27 Sep 2026 · Wissen Weekly

Fin de l'état de grâce pour l'Allemagne de Klopp, battue par la Grèce – 27/09 7 min · 27 Sep 2026 · L'After Foot

Report any issue

Source

Recorded03 Jun 2025

Publisherfeeds.podcastai.com ↗

Handlerec:10161865

Show notes

In this episode, Bob delves into the FDA's introduction of an AI tool named Elsa designed to streamline drug approvals and discusses its potential impact on the pharmaceutical industry. The conversation then shifts to Yoshua Bengio's new non-profit, LawZero, which aims to enhance AI safety. Bob highlights Google's AI Edge Gallery app, which facilitates the use of offline AI models, potentially broadening AI's reach. The episode also covers Meta's innovative use of AI-driven automation in ad creation, revolutionizing marketing strategies. A sponsor segment is included, followed by Bob's closing thoughts.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in